ABOUT US
Investors
CDC Innovation

CDC Innovation is an international venture capital firm founded in 1996, with its head office in Paris and a local presence in the Silicon Valley and in Switzerland. With over 415 M€ currently under management, our focus is on venture investments at both the early and late stage, in two sectors: information technologies and life sciences. Our aim is to create value by providing talented entrepreneurs with the resources, experience, and network necessary to turn world-class technologies into great businesses.
http://www.cdcinnovation.com
TechFund Europe

In the 1990's TechFund was conceived by entrepreneurs who thought something was broken with the classical venture capital model. As the TechFund founders experienced the quest for funding in Silicon Valley and in European tech centers, it was clear that there were few venture guys who had ever really done a start-up themselves.
The VC's often seemed surprised to find out that entrepreneurs needed not only assistance in funding but some hands-on support in building a team, re-imagining a market, or leveraging an international network. It seemed like the venture guys were on one side, and the entrepreneurs on the other. The founders believed that this was an opportunity for re-imagining how a venture capital relationship could be built.
As a result TechFund was founded as a multi-stage fund that could start early, apply its talents on growing the start-up, and still have the ability to support it to a successful IPO or sale. TechFund learned not only did today's entrepreneurs need experienced VC partners, but that they needed to be networked at the earliest possible time to international corporate partners. Indeed, start-ups needed to have a global understanding of the forces and the competition that would impact their business. TechFund's unique emphasis on leveraging the fund's international corporate investors helped its start-ups accelerate their global ambitions and understanding.
Today TechFund is a leading international venture team who is able to leverage its global track record and experience to build the NEXT generation of successful start-ups.
http://www.techfund.com
Siparex

As an independent French private equity specialist investing in SMEs, the SIPAREX group manages €850m in assets, 19% of which in venture capital, through a dedicated subsidiary with an autonomous staff of 10 associates based in Paris and Lyon. Siparex’s funds have been invested since the creation of the company.
http://www.siparex.com
Groupe IDI

IDI is a company listed on the stock market for the past 15 years, majority-owned by managers. It specializes in the purchase of financial interests, generally majority stakes, in unlisted companies and then in providing long-term support and development. Investments concern mostly French companies and reach between €1 to 15 million. IDI portfolio now� has around thirty different holdings.
In the years ahead, IDI's ambition is to achieve net profitability of 15% p.a. for shareholders, 2,5% of which would be distributed annually and the remainder reinvested.
http://www.idi.fr/
INRETS

INRETS was created in 1985 by an interdepartmental decree. It is in charge of technologic development in order to implement transport systems and circulation, from a technical, economical and social point of view.
http://www.inrets.fr/